Last reviewed: June 10, 2026
Last updated: June 10, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Ozempic (semaglutide) and Mounjaro (tirzepatide) are both GLP-1 medications that reduce appetite and improve blood sugar control, but head-to-head studies reveal different weight loss trajectories. Tirzepatide acts on two hormone pathways instead of one, which may explain why some people see faster results—but response depends heavily on individual genetics and metabolic factors.
Clinical Trial Data: Tirzepatide vs Semaglutide Weight Loss
In the SURPASS-4 trial, people taking tirzepatide at the highest dose lost an average of 22.5% of their body weight over 52 weeks, compared to 16.0% with high-dose semaglutide in separate studies. This roughly 6-percentage-point advantage appears consistent across age groups and BMI categories, though individual variation is substantial. It's important to note that tirzepatide targets both the GLP-1 and GIP hormone receptors, while semaglutide targets only GLP-1, which may account for the difference in magnitude.
Not every person on tirzepatide outperforms every person on semaglutide—some individuals respond remarkably well to semaglutide alone, while others require dual-pathway activation to see meaningful weight loss. Factors like baseline insulin resistance, genetic predisposition to hunger signaling, and adherence to lifestyle changes all influence the final outcome. PlexusDx recognizes this variability and uses genetic insights to predict which compound may be your best match.
How Tirzepatide's Dual-Pathway Mechanism Works Differently
Tirzepatide activates both GLP-1 and GIP receptors in the brain and gut, triggering a more comprehensive appetite shutdown and metabolic shift compared to semaglutide's single GLP-1 pathway. The GIP pathway also influences how your body processes and stores fat, potentially enhancing weight loss beyond appetite reduction alone. This dual action may be why some patients experience greater satiety and report easier adherence to smaller meal portions.
Semaglutide, by contrast, works primarily through the GLP-1 receptor to slow stomach emptying and increase feelings of fullness. For people with certain genetic variants in the GLP1R gene, semaglutide can be just as effective as tirzepatide; for others, the single pathway may not be sufficient to override their hunger signals. This is where personalized genetic testing becomes valuable—it helps identify whether your body is more responsive to single or dual-pathway stimulation.
Genetic Factors That Predict Your Weight Loss Response
PlexusDx's Precision Peptide Genetic Test analyzes variants in key appetite-regulation genes, including GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313), to forecast how your body will respond to each medication. A person carrying specific variants in the GIPR gene may see significantly better results on tirzepatide because their GIP receptors are more sensitive to activation. Conversely, some individuals have GLP1R variants that make semaglutide equally potent, even at lower doses.
The FTO and MC4R genes influence baseline metabolic rate and appetite drive; variants in these genes can mean the difference between needing aggressive dual-pathway therapy versus responding well to a single-compound approach. PlexusDx maps 49 peptides across 14 metabolic pathways to build a complete picture of your weight loss potential, allowing your provider to select the compound most aligned with your genetic profile. This precision approach reduces trial-and-error and accelerates results.
Cost, Access, and Personalized Tirzepatide Options at PlexusDx
PlexusDx offers Compounded Tirzepatide Injection starting at $249 per month—a flat rate that never increases with dose adjustments, so your dose may need to go up while your price stays the same. Tirzepatide is available without insurance, no membership fees, and is HSA/FSA eligible, making it accessible to anyone seeking precision weight loss therapy. All medications come from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality and sterility.
For those wanting the benefits of both semaglutide and tirzepatide or seeking to rotate between pathways, PlexusDx also provides GLP-Squared Injection (a dual compound combining both therapeutics) starting at $249 per month. After your first month of treatment, you can add the Precision Peptide Genetic Test for $99 to unlock detailed insights into your specific peptide-pathway responses and optimize your ongoing therapy. This combination of personalized testing and flexible medication options ensures you're matched with the approach most likely to deliver meaningful weight loss for your body.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Who typically loses more weight faster—people on Ozempic or Mounjaro?
On average, people taking tirzepatide (Mounjaro) lose about 6% more body weight than those on semaglutide (Ozempic) across clinical trials, but this varies widely by individual. Your genetic predisposition to respond to GLP-1 versus dual GLP-1/GIP signaling is the strongest predictor of your personal outcome. PlexusDx's Precision Peptide Genetic Test reveals your likely response pattern before you start, helping your provider choose the optimal compound.
Why does tirzepatide work on two hormone pathways instead of one?
Tirzepatide was designed to target both GLP-1 and GIP receptors because research showed that activating both pathways produces greater appetite suppression and metabolic improvement than either alone. The GIP pathway also modulates fat storage and glucose processing, adding an extra layer of metabolic benefit. For people with genetic variants that make them less sensitive to GLP-1 signaling alone, this dual approach is often more effective.
Does PlexusDx charge more if my tirzepatide dose increases over time?
No. PlexusDx Compounded Tirzepatide Injection costs $249 per month flat, regardless of dose level—your dose may need to go up, but your price won't. This pricing structure makes it predictable and affordable to adjust your treatment as your body responds and your provider optimizes your therapy.
Can I switch between semaglutide and tirzepatide if one doesn't work well?
Yes, your PlexusDx provider can help you transition between compounds if you're not seeing desired results after a reasonable trial period. Your Precision Peptide Genetic Test results guide this decision by showing which pathways your body is most responsive to, reducing guesswork and accelerating success with the next medication.
What does PlexusDx's Precision Peptide Genetic Test actually measure?
The test analyzes 14 metabolic pathways and 49 peptides linked to weight regulation, appetite signaling, and fat storage—including key variants in GLP1R, GIPR, FTO, and MC4R genes. It's a peptide-pathway genetic test (not pharmacogenomic) designed specifically to predict your response to GLP-1 and GIP-based therapies, helping your provider personalize your medication selection and dosing strategy.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Do You Inject Ozempic Every Day? Understanding the Dosing Schedule
Finding Relief: Does Ozempic Help with Hot Flashes and Menopause Weight Gain?